Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

RAPT Therapeutics, Inc. - Common Stock (NQ:RAPT)

28.85 +1.06 (+3.81%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about RAPT Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
RAPT Stock Earnings: RAPT Therapeutics Beats EPS for Q1 2024 ↗
RAPT stock results show that RAPT Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
3 Biotech Stocks to Dump Before They Go to Zero ↗
These biotech stocks to sell are burning through cash at an alarming rate and seem destined for zero, making them prime targets for selling. 
Via InvestorPlace
News headline image
RAPT Stock Earnings: RAPT Therapeutics Beats EPS for Q4 2023 ↗
RAPT stock results show that RAPT Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
RAPT Therapeutics: Q4 Earnings Insights ↗
 
Via Benzinga
News headline image
Rivian Automotive Reports Q4 Loss, Joins Etsy, Lucid Group And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
U.S. stock futures were higher this morning, with the Nasdaq futures trading higher by around 2% on Thursday. 
Via Benzinga
News headline image
Recap: RAPT Therapeutics Q3 Earnings ↗
 
Via Benzinga
News headline image
Analyst Ratings for RAPT Therapeutics ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for RAPT Therapeutics ↗
 
Via Benzinga
News headline image
What's Going On With RAPT Therapeutics Stock On Wednesday? ↗
Latest developments in RAPT Therapeutics as FDA places clinical hold on Phase 2b trial for zelnecirnon in dermatitis and asthma. Stock rebounds and analyst downgrades. 
Via Benzinga
News headline image
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Analyst Ratings for RAPT Therapeutics ↗
 
Via Benzinga
News headline image
Analyst Expectations for RAPT Therapeutics's Future ↗
 
Via Benzinga
News headline image
Recap: RAPT Therapeutics Q1 Earnings ↗
 
Via Benzinga
News headline image
Stocks Slip Ahead Of Fed Minutes, Nvidia Earnings ↗
Stocks are lower today, with the Nasdaq Composite Index (IXIC) leading the losses as investors reassess a potentially overvalued tech sector. 
Via Talk Markets
Topics Economy Stocks
News headline image
Crude Oil Moves Lower; Summit Therapeutics Shares Plummet ↗
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 200 points on Tuesday. The Dow traded down 0.18% to 38,557.86 while the NASDAQ fell 1.30% to 15,570.84. The... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Is Inflammatory Disease/Oncology-Focused RAPT Therapeutics Shares Tumbling Today? ↗
FDA places clinical hold on RAPT Therapeutics' Phase 2 trials for zelnecirnon in atopic dermatitis and asthma. 
Via Benzinga
News headline image
Rapt Therapeutics Crashes 65% After Unexpected Liver Failure Sidelines Two Tests ↗
The FDA put studies in eczema and asthma treatment on clinical hold. 
Via Investor's Business Daily
News headline image
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results. 
Via Benzinga
News headline image
Dow Dips Over 100 Points; US Leading Economic Index Falls In January ↗
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 1.5% on Tuesday. The Dow traded down 0.35% to 38,494.51 while the NASDAQ fell 1.51% to 15,537.95. The S&P 500... 
Via Benzinga
Topics Stocks
News headline image
Dow Rebounds; Nasdaq Drops Triple Digits ↗
Nvidia stock is sliding ahead of tomorrow's earnings report 
Via Talk Markets
Topics Stocks
News headline image
Nasdaq Down 1%; Capital One Set To Buy Discover ↗
U.S. stocks traded lower this morning, with the Nasdaq Composite falling around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.05% to 38,607.53 while the NASDAQ fell... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
7 ‘Strong Buy’ Biotech Stocks to Rejuvenate Your Portfolio ↗
Dive into these seven strong buy biotech stocks, handpicked by Wall Street, to inject vigor into your investment game. 
Via InvestorPlace
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2023 ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023 ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2023 ↗
 
Via Benzinga
News headline image
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.